DR
DRW3.XETRA Drägerwerk AG & Co. KGaA (pref)
- Market cap
- EUR 1.91B
- P/E
- 11.3x
- P/B
- 1.17x
- ROE
- 5.8%
- Dividend yield
- 1.97%
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.
Is DRW3.XETRA undervalued?
Graham numberDRW3.XETRA trades 23.5% below its Graham number.
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Drägerwerk AG & Co. KGaA (pref) fundamental analysis
No fundamental analysis for Drägerwerk AG & Co. KGaA (pref) yet.
Drägerwerk AG & Co. KGaA (pref) stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Drägerwerk AG & Co. KGaA (pref)
Drägerwerk AG & Co. KGaA operates as a medical and safety technology company worldwide. It develops, produces, and markets system solutions, devices, and services for the medical division, including emergency medicine, perioperative care, intensive care, and perinatal medicine. The company also develops, produces, and markets products, system solutions, and services for personal protection, gas measurement technology, and comprehensive risk management to customers in industr…
Full company profileDrägerwerk AG & Co. KGaA (pref) financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 3 quarters up to Sep 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Drägerwerk AG & Co. KGaA (pref) annual financial statements (EUR; K = thousand, M = million, B = billion, T = trillion)
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 2.52B | 2.57B | 2.60B | 2.78B | 3.41B | 3.33B | 3.05B | 3.37B | 3.37B | 3.48B | 3.27B |
| Gross Profit | 1.14B | 1.15B | 1.11B | 1.19B | 1.61B | 1.54B | 1.24B | 1.46B | 1.51B | 1.52B | 1.53B |
| Operating Income | 154M | 153M | 64.1M | 84.3M | 412M | 281M | -79.8M | 184M | 167M | 238M | 153M |
| EBITDA | 141M | 159M | 66.6M | 98.8M | 423M | 285M | 62.6M | 318M | 352M | 385M | 287M |
| Net Income | 82.1M | 98.5M | 34.4M | 33.4M | 250M | 154M | -64.6M | 110M | 124M | 139M | 99.9M |
| EPS | 4.62 | 5.54 | 1.93 | 1.88 | 14 | 8.22 | -3.44 | 5.89 | 6.63 | 7.44 | 5.33 |
| Balance Sheet | |||||||||||
| Total Assets | 2.31B | 2.35B | 2.41B | 2.57B | 3.31B | 3.18B | 3.11B | 3.09B | 3.09B | 3.28B | 3.26B |
| Total Liabilities | 1.31B | 1.29B | 1.33B | 1.49B | 2.27B | 1.92B | 1.79B | 1.69B | 1.56B | 1.65B | 1.55B |
| Shareholders' Equity | 1.00B | 1.07B | 1.08B | 1.07B | 1.03B | 1.26B | 1.32B | 1.41B | 1.54B | 1.63B | 1.71B |
| Cash & Short-term Investments | 217M | 243M | 177M | 192M | 651M | 577M | 319M | 279M | 248M | 284M | 271M |
| Total Debt | 256M | 218M | 223M | 285M | 371M | 348M | 362M | 471M | 396M | 405M | 229M |
| Cash Flow | |||||||||||
| Operating Cash Flow | 195M | 143M | 4.09M | 164M | 460M | 385M | -144M | 190M | 167M | 238M | 233M |
| Capital Expenditure | 79.8M | 70.7M | 61.7M | 64.4M | 115M | 110M | 86.9M | 68.2M | 63.8M | 71.8M | 87.4M |
| Free Cash Flow | 116M | 72.6M | -57.6M | 100M | 345M | 275M | -231M | 121M | 104M | 167M | 146M |
| Ratios | |||||||||||
| ROE | 8.2% | 9.2% | 3.2% | 3.1% | 24.2% | 12.2% | -4.9% | 7.9% | 8.1% | 8.6% | 5.8% |
| ROA | 3.5% | 4.2% | 1.4% | 1.3% | 7.6% | 4.9% | -2.1% | 3.6% | 4.0% | 4.3% | 3.1% |
| Net Profit Margin | 3.3% | 3.8% | 1.3% | 1.2% | 7.3% | 4.6% | -2.1% | 3.3% | 3.7% | 4.0% | 3.1% |
| Debt to Equity | 0.26x | 0.20x | 0.21x | 0.27x | 0.36x | 0.28x | 0.27x | 0.34x | 0.26x | 0.25x | 0.13x |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Drägerwerk AG & Co. KGaA (pref) dividends
- Dividend yield
- 1.97%
- Forward dividend
- 2.27 EUR
- Payout ratio
- 26.9%
- Ex-dividend date
- May 11, 2026
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | EUR 37.5M | 2.00 | 26.9% |
| 2024 | EUR 33.2M | 1.77 | 26.7% |
| 2023 | EUR 3.68M | 0.20 | 3.3% |
| 2022 | EUR 3.68M | 0.20 | - |
| 2021 | EUR 4.05M | 0.22 | 2.6% |
| 2020 | EUR 5.45M | 0.30 | 2.2% |
| 2019 | EUR 4.00M | 0.23 | 12.0% |
| 2018 | EUR 11.0M | 0.62 | 32.1% |
| 2017 | EUR 4.00M | 0.23 | 4.1% |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Last stock split: 657:613 on Jun 17, 2010.
Who owns Drägerwerk AG & Co. KGaA (pref)
- Insiders 0.00%
- Institutions 33.69%
- Public & others 66.31%
- Shares outstanding 8.60M
- Free float 11.6M
Drägerwerk AG & Co. KGaA (pref) company profile
- Company name
- Drägerwerk AG & Co. KGaA (pref)
- Ticker
- DRW3.XETRA
- ISIN
- DE0005550636
- Exchange
- XETRA Stock Exchange
- Sector
- Healthcare
- Industry
- Health Care Equipment & Supplies
- Employees
- 16,716
- Fiscal year end
- December
- Address
- Moislinger Allee 53-55, Lübeck, Germany, 23542
- Phone
- 49 451 882 3202
- Website
- draeger.com
About Drägerwerk AG & Co. KGaA (pref)
Drägerwerk AG & Co. KGaA operates as a medical and safety technology company worldwide. It develops, produces, and markets system solutions, devices, and services for the medical division, including emergency medicine, perioperative care, intensive care, and perinatal medicine. The company also develops, produces, and markets products, system solutions, and services for personal protection, gas measurement technology, and comprehensive risk management to customers in industry and mining sectors, as well as public sectors, such as fire departments, police, and disaster protection. In addition, it offers patient monitoring systems; anaesthesia machines; medical ventilators and lung monitoring; neonatal incubators and thermoregulation; phototherapy lights and bilirubinometers; surgical and examination lights; medical pendants and infrastructure design; medical gas pipeline system in hospitals; and hospital consumables and accessories, as well as hospital planning and design services. Further, the company offers alcohol and drug testing; diving equipment; fixed gas detectors; hazmat suits; portable gas detection; head and eye protection; rescue and escape; respiratory protection; safety-training systems; thermal imaging cameras; and workshop solution and breathing gas supply, as well as provides various training and services. The company was founded in 1889 and is headquartered in Lübeck, Germany. Drägerwerk AG & Co. KGaA operates as a subsidiary of Dr. Heinrich Dräger GmbH.
Drägerwerk AG & Co. KGaA (pref) management
8- Mr. Stefan A. Drager B.A.Chairman of the Executive Board - Drägerwerk Verwaltungs AG · born 1963
- Mr. Gert-Hartwig LescowCFO, Executive Board Member for IT & Vice Chairman of Executive Board - Drägerwerk Verwaltungs AG · born 1967
- Mr. Anton SchrofnerExecutive Board Member for Medical Division - Drägerwerk Verwaltungs AG · born 1963
- Mr. Rainer KlugExecutive Board Member for Safety Division - Drägerwerk Verwaltungs AG · born 1968
- Dr. Reiner PiskeExecutive Board Member for Sales & Services - Drägerwerk Verwaltungs AG · born 1970
- Ms. Stefanie HirschExecutive Board Member for HR, Sustainability & Quality - Drägerwerk Verwaltungs AG · born 1975
- Mr. Thomas FischlerHead of Treasury & Investor Relations
- Mr. Welf BöttcherHead of Corporate Communications